Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established During Clinical Trial 38826 for the Development of Org 36286 (Corifollitropin Alfa).
Brief Summary: The objective of this trial was to evaluate whether Org 36286 treatment for the induction of multifollicular growth in women undergoing controlled ovarian stimulation (COS) for in vitro fertilization (IVF) or intracytoplasmatic sperm injection (ICSI) is safe for pregnant subjects and their offspring.


Options:
A: Arm Label: Experimental Group 1; Type: N/A; Interventions: Drug: Org 36286 (corifollitropin alfa) | Arm Label: Experimental Group 2; Type: N/A; Interventions: Drug: Placebo | Arm Label: Experimental Group 3; Type: N/A; Interventions: Drug: Org 36286 (corifollitropin alfa) | Arm Label: Experimental Group 4; Type: N/A; Interventions: Drug: recFSH | Intervention Type: DRUG; Name: Org 36286 (corifollitropin alfa); Assigned to Arm(s): Experimental Group 1, Experimental Group 3 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Experimental Group 2 | Intervention Type: DRUG; Name: recFSH; Assigned to Arm(s): Experimental Group 4
B: Arm Label: Experimental Group 1; Type: N/A; Interventions: Drug: Org 36286 | Arm Label: Experimental Group 2; Type: N/A; Interventions: Drug: recFSH | Intervention Type: DRUG; Name: Org 36286; Assigned to Arm(s): Experimental Group 1 | Intervention Type: DRUG; Name: recFSH; Assigned to Arm(s): Experimental Group 2
C: Arm Label: Corifollitropin alfa 150 µg; Type: EXPERIMENTAL; Interventions: Drug: Corifollitropin alfa, Biological: FSH, Biological: GnRH antagonist, Biological: (rec)hCG, Drug: Progesterone | Intervention Type: DRUG; Name: Corifollitropin alfa; Assigned to Arm(s): Corifollitropin alfa 150 µg | Intervention Type: BIOLOGICAL; Name: FSH; Assigned to Arm(s): Corifollitropin alfa 150 µg | Intervention Type: BIOLOGICAL; Name: GnRH antagonist; Assigned to Arm(s): Corifollitropin alfa 150 µg | Intervention Type: BIOLOGICAL; Name: (rec)hCG; Assigned to Arm(s): Corifollitropin alfa 150 µg | Intervention Type: DRUG; Name: Progesterone; Assigned to Arm(s): Corifollitropin alfa 150 µg
D: Arm Label: Corifollitropin alfa 100 μg; Type: N/A; Interventions: Drug: Corifollitropin alfa, Drug: gonadatropin releasing hormone (GnRH) antagonist ganirelix, Biological: human chorion gonadotropin (hCG), Biological: progesterone, Drug: placebo-recFSH (follitropin beta), Biological: open-label recFSH (follitropin beta) | Arm Label: recFSH 150 IU; Type: N/A; Interventions: Biological: recFSH (follitropin beta), Drug: gonadatropin releasing hormone (GnRH) antagonist ganirelix, Biological: human chorion gonadotropin (hCG), Biological: progesterone, Drug: placebo-corifollitropin alfa, Biological: open-label recFSH (follitropin beta) | Intervention Type: DRUG; Name: Corifollitropin alfa; Assigned to Arm(s): Corifollitropin alfa 100 μg | Intervention Type: BIOLOGICAL; Name: recFSH (follitropin beta); Assigned to Arm(s): recFSH 150 IU | Intervention Type: DRUG; Name: gonadatropin releasing hormone (GnRH) antagonist ganirelix; Assigned to Arm(s): Corifollitropin alfa 100 μg, recFSH 150 IU | Intervention Type: BIOLOGICAL; Name: human chorion gonadotropin (hCG); Assigned to Arm(s): Corifollitropin alfa 100 μg, recFSH 150 IU | Intervention Type: BIOLOGICAL; Name: progesterone; Assigned to Arm(s): Corifollitropin alfa 100 μg, recFSH 150 IU | Intervention Type: DRUG; Name: placebo-recFSH (follitropin beta); Assigned to Arm(s): Corifollitropin alfa 100 μg | Intervention Type: DRUG; Name: placebo-corifollitropin alfa; Assigned to Arm(s): recFSH 150 IU | Intervention Type: BIOLOGICAL; Name: open-label recFSH (follitropin beta); Assigned to Arm(s): Corifollitropin alfa 100 μg, recFSH 150 IU

Answer: B